Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.4M Buy
14,901
+284
+2% +$97.2K 0.55% 42
2026
Q1
$5.14M Buy
14,617
+642
+5% +$229K 0.59% 37
2025
Q4
$4.57M Buy
13,975
+12,442
+812% +$3.95M 0.53% 41
2025
Q3
$433K Buy
1,533
+300
+24% +$87K 0.05% 286
2025
Q2
$344K Sell
1,233
-223
-15% -$63.2K 0.04% 299
2025
Q1
$454K Buy
1,456
+199
+16% +$58.8K 0.06% 237
2024
Q4
$328K Buy
+1,257
New +$373K 0.05% 275

Other funds holding AMGN

Novem Group's AMGN Position: Q2 2026 in Review

Novem Group increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $97.2K and bringing the position to 14,901 shares worth $5.4M. The position accounts for 0.55% of the portfolio, ranked #42.

Novem Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Novem Group held 14,901 shares of Amgen worth $5.4M as of Q2 2026.
  • Novem Group bought 284 Amgen shares in Q2 2026, an estimated $97.2K.
  • Amgen made up 0.55% of Novem Group's portfolio in Q2 2026, its #42 holding.
  • Novem Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.